Rhythm Biosciences Ltd has released a press release.
RHY Advances Platform Expansion with Other Cancers
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Application for quotation of securities - RHY
- Completion of Final TGA Submission Step to Approve ColoSTAT
- Rhythm Closes Final Clinical Trial Site
- Appendix 4C - quarterly
- Rhythm Biosciences: RHY Presentation at PAC Partners Healthcare Conference
Later from Rhythm Biosciences
- Director Share Sale To Institutional Funds Manager
- Rhythm Receives $2.7m R&D Tax Incentive
- ColoSTAT Authorised For Sale In New Zealand
- Healthcare Conference Investor Presentation
- RHY 2022 AGM Presentation
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences